QUAGLINO, Elena
QUAGLINO, Elena
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
'In Vitro', 'In Vivo' and 'In Silico' Investigation of the Anticancer Effectiveness of Oxygen-Loaded Chitosan-Shelled Nanodroplets as Potential Drug Vector
2018-01-01 Khadjavi, Amina; Stura, Ilaria; Prato, Mauro; Minero, Valerio Giacomo; Panariti, Alice; Rivolta, Ilaria; Gulino, Giulia Rossana; Bessone, Federica; Giribaldi, Giuliana; Quaglino, Elena; Cavalli, Roberta; Cavallo, Federica; Guiot, Caterina
2H,3H-decafluoropentane-based nanodroplets: New perspectives for oxygen delivery to hypoxic cutaneous tissues
2015-01-01 Prato, Mauro; Magnetto, Chiara; Jose, Jithin; Khadjavi, Amina; Cavallo, Federica; Quaglino, Elena; Panariti, Alice; Rivolta, Ilaria; Benintende, Emilio; Varetto, Gianfranco; Argenziano, Monica; Troia, Adriano; Cavalli, Roberta; Guiot, Caterina
A better immune reaction to Erbb-2
2010-01-01 Quaglino E; Mastini C; Riccardo F; Ercole E; Montani M; Forni G; Cavallo F
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins
2010-01-01 Quaglino E; Mastini C; Amici A; Marchini C; Iezzi M; Lanzardo S; De Giovanni C; Montani M; Lollini PL; Masucci G; Forni G; Cavallo F.
A chimeric human/dog-DNA vaccine against CSPG4 induces immunity with therapeutic potential in comparative preclinical models of osteosarcoma
2023-01-01 Tarone, Lidia; Giacobino, Davide; Camerino, Mariateresa; Maniscalco, Lorella; Iussich, Selina; Parisi, Lorenza; Giovannini, Giuseppe; Dentini, Alfredo; Bolli, Elisabetta; Quaglino, Elena; Merighi, Irene Fiore; Morello, Emanuela; Buracco, Paolo; Riccardo, Federica; Cavallo, Federica
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia.
2001-01-01 Cifaldi L; Quaglino E; Di Carlo E; Musiani P; Spadaro M; Lollini PL; Wolf S; Boggio K; Forni G; Cavallo F.
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice
2005-01-01 LO IACONO M; CAVALLO F; QUAGLINO E; ROLLA S; IEZZI M; PUPA SM; DE GIOVANNI C; LOLLINI PL; MUSIANI P; FORNI G; CALOGERO RA
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice.
2000-01-01 BOGGIO K;DI CARLO E;ROVERO S;CAVALLO F;QUAGLINO E;LOLLINI PL;NANNI P;NICOLETTI G;WOLF S;MUSIANI P;FORNI G
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice.
2000-01-01 Boggio K; Di Carlo E; Rovero S; Cavallo F; Quaglino E; Lollini PL; Nanni P; Nicoletti G; Wolf S; Musiani P; Forni G.
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial
2022-01-01 Riccardo, Federica; Tarone, Lidia; Camerino, Mariateresa; Giacobino, Davide; Iussich, Selina; Barutello, Giuseppina; Arigoni, Maddalena; Conti, Laura; Bolli, Elisabetta; Quaglino, Elena; Merighi, Irene Fiore; Morello, Emanuela; Dentini, Alfredo; Ferrone, Soldano; Buracco, Paolo; Cavallo, Federica
Antitumor immunization of mothers delays tumor development in cancer-prone offspring
2015-01-01 Barutello, Giuseppina; Curcio, Claudia; Spadaro, Michela; Arigoni, Maddalena; Trovato, Rosalinda; Bolli, Elisabetta; Zheng, Yujuan; Ria, Francesco; Quaglino, Elena; Iezzi, Manuela; Riccardo, Federica; Holmgren, Lars; Forni, Guido; Cavallo, Federica
Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2+mammary cancer
2016-01-01 Jacca, Sarah; Rolih, Valeria; Quaglino, Elena; Franceschi, Valentina; Tebaldi, Giulia; Bolli, Elisabetta; Rosamilia, Alfonso; Ottonello, Simone; Cavallo, Federica; Donofrio, Gaetano
Breast cancer stem cell antigens as targets for immunotherapy
2020-01-01 Quaglino E.; Conti L.; Cavallo F.
Cancer stem cell antigens as targets for new combined anti-cancer therapies
2020-01-01 Quaglino E.; Cavallo F.; Conti L.
Cancer vaccines: Target antigens, vaccine platforms and preclinical models
2024-01-01 Ruzzi F.; Riccardo F.; Conti L.; Tarone L.; Semprini M.S.; Bolli E.; Barutello G.; Quaglino E.; Lollini P.-L.; Cavallo F.
Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers.
2014-01-01 Riccardo F;Arigoni M;Buson G;Zago E;Iezzi M;Longo D;Carrara M;Fiore A;Nuzzo S;Bicciato S;Nanni P;Landuzzi L;Cavallo F;Calogero R;Quaglino E
Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans.
2011-01-01 Quaglino E; Riccardo F; Macagno M; Bandini S; Cojoca R; Ercole E; Amici A; Cavallo F.
Chimeric DNA Vaccines: An Effective Way to Overcome Immune Tolerance.
2017-01-01 F. Riccardo;E. Bolli;M. Macagno;M. Arigoni;F. Cavallo;E. Quaglino
Combining human and rat sequences in her-2 DNA vaccines blunts immune tolerance and drives antitumor immunity.
2010-01-01 Jacob JB; Quaglino E; Radkevich-Brown O; Jones RF; Piechocki MP; Reyes JD; Weise A; Amici A; Wei WZ.
Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions
2004-01-01 QUAGLINO E; ROLLA S; IEZZI M; SPADARO M; MUSIANI P; DE GIOVANNI C; LOLLINI PL; LANZARDO S; FORNI G; SANGES R; CRISPI S; DE LUCA P; CALOGERO R; CAVALLO F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 'In Vitro', 'In Vivo' and 'In Silico' Investigation of the Anticancer Effectiveness of Oxygen-Loaded Chitosan-Shelled Nanodroplets as Potential Drug Vector | 2018 | Khadjavi, Amina; Stura, Ilaria; Prato, Mauro; Minero, Valerio Giacomo; Panariti, Alice; Rivolta, Ilaria; Gulino, Giulia Rossana; Bessone, Federica; Giribaldi, Giuliana; Quaglino, Elena; Cavalli, Roberta; Cavallo, Federica; Guiot, Caterina | |
| 2H,3H-decafluoropentane-based nanodroplets: New perspectives for oxygen delivery to hypoxic cutaneous tissues | 2015 | Prato, Mauro; Magnetto, Chiara; Jose, Jithin; Khadjavi, Amina; Cavallo, Federica; Quaglino, Elena; Panariti, Alice; Rivolta, Ilaria; Benintende, Emilio; Varetto, Gianfranco; Argenziano, Monica; Troia, Adriano; Cavalli, Roberta; Guiot, Caterina | |
| A better immune reaction to Erbb-2 | 2010 | Quaglino E; Mastini C; Riccardo F; Ercole E; Montani M; Forni G; Cavallo F | |
| A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins | 2010 | Quaglino E; Mastini C; Amici A; Marchini C; Iezzi M; Lanzardo S; De Giovanni C; Montani M; Lollini PL; Masucci G; Forni G; Cavallo F. | |
| A chimeric human/dog-DNA vaccine against CSPG4 induces immunity with therapeutic potential in comparative preclinical models of osteosarcoma | 2023 | Tarone, Lidia; Giacobino, Davide; Camerino, Mariateresa; Maniscalco, Lorella; Iussich, Selina; Parisi, Lorenza; Giovannini, Giuseppe; Dentini, Alfredo; Bolli, Elisabetta; Quaglino, Elena; Merighi, Irene Fiore; Morello, Emanuela; Buracco, Paolo; Riccardo, Federica; Cavallo, Federica | |
| A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. | 2001 | Cifaldi L; Quaglino E; Di Carlo E; Musiani P; Spadaro M; Lollini PL; Wolf S; Boggio K; Forni G; Cavallo F. | |
| A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice | 2005 | LO IACONO M; CAVALLO F; QUAGLINO E; ROLLA S; IEZZI M; PUPA SM; DE GIOVANNI C; LOLLINI PL; MUSIANI P; FORNI G; CALOGERO RA | |
| Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. | 2000 | BOGGIO K;DI CARLO E;ROVERO S;CAVALLO F;QUAGLINO E;LOLLINI PL;NANNI P;NICOLETTI G;WOLF S;MUSIANI P;FORNI G | |
| Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. | 2000 | Boggio K; Di Carlo E; Rovero S; Cavallo F; Quaglino E; Lollini PL; Nanni P; Nicoletti G; Wolf S; Musiani P; Forni G. | |
| Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial | 2022 | Riccardo, Federica; Tarone, Lidia; Camerino, Mariateresa; Giacobino, Davide; Iussich, Selina; Barutello, Giuseppina; Arigoni, Maddalena; Conti, Laura; Bolli, Elisabetta; Quaglino, Elena; Merighi, Irene Fiore; Morello, Emanuela; Dentini, Alfredo; Ferrone, Soldano; Buracco, Paolo; Cavallo, Federica | |
| Antitumor immunization of mothers delays tumor development in cancer-prone offspring | 2015 | Barutello, Giuseppina; Curcio, Claudia; Spadaro, Michela; Arigoni, Maddalena; Trovato, Rosalinda; Bolli, Elisabetta; Zheng, Yujuan; Ria, Francesco; Quaglino, Elena; Iezzi, Manuela; Riccardo, Federica; Holmgren, Lars; Forni, Guido; Cavallo, Federica | |
| Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2+mammary cancer | 2016 | Jacca, Sarah; Rolih, Valeria; Quaglino, Elena; Franceschi, Valentina; Tebaldi, Giulia; Bolli, Elisabetta; Rosamilia, Alfonso; Ottonello, Simone; Cavallo, Federica; Donofrio, Gaetano | |
| Breast cancer stem cell antigens as targets for immunotherapy | 2020 | Quaglino E.; Conti L.; Cavallo F. | |
| Cancer stem cell antigens as targets for new combined anti-cancer therapies | 2020 | Quaglino E.; Cavallo F.; Conti L. | |
| Cancer vaccines: Target antigens, vaccine platforms and preclinical models | 2024 | Ruzzi F.; Riccardo F.; Conti L.; Tarone L.; Semprini M.S.; Bolli E.; Barutello G.; Quaglino E.; Lollini P.-L.; Cavallo F. | |
| Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers. | 2014 | Riccardo F;Arigoni M;Buson G;Zago E;Iezzi M;Longo D;Carrara M;Fiore A;Nuzzo S;Bicciato S;Nanni P;Landuzzi L;Cavallo F;Calogero R;Quaglino E | |
| Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans. | 2011 | Quaglino E; Riccardo F; Macagno M; Bandini S; Cojoca R; Ercole E; Amici A; Cavallo F. | |
| Chimeric DNA Vaccines: An Effective Way to Overcome Immune Tolerance. | 2017 | F. Riccardo;E. Bolli;M. Macagno;M. Arigoni;F. Cavallo;E. Quaglino | |
| Combining human and rat sequences in her-2 DNA vaccines blunts immune tolerance and drives antitumor immunity. | 2010 | Jacob JB; Quaglino E; Radkevich-Brown O; Jones RF; Piechocki MP; Reyes JD; Weise A; Amici A; Wei WZ. | |
| Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions | 2004 | QUAGLINO E; ROLLA S; IEZZI M; SPADARO M; MUSIANI P; DE GIOVANNI C; LOLLINI PL; LANZARDO S; FORNI G; SANGES R; CRISPI S; DE LUCA P; CALOGERO R; CAVALLO F. |